Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.362
EU - Europa 6.718
AS - Asia 6.525
SA - Sud America 963
AF - Africa 173
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.947
SE - Svezia 2.385
SG - Singapore 2.131
IT - Italia 1.431
VN - Vietnam 1.415
CN - Cina 1.082
HK - Hong Kong 877
RU - Federazione Russa 734
BR - Brasile 716
DE - Germania 699
IE - Irlanda 344
CA - Canada 319
GB - Regno Unito 280
FR - Francia 207
IN - India 203
BD - Bangladesh 129
KR - Corea 129
FI - Finlandia 113
ID - Indonesia 102
AR - Argentina 96
NL - Olanda 91
IQ - Iraq 68
AT - Austria 64
ZA - Sudafrica 64
ES - Italia 63
PL - Polonia 59
TR - Turchia 56
CH - Svizzera 55
MX - Messico 49
SA - Arabia Saudita 41
UA - Ucraina 41
MY - Malesia 39
PH - Filippine 39
EC - Ecuador 34
PK - Pakistan 33
CO - Colombia 29
JP - Giappone 28
DK - Danimarca 27
VE - Venezuela 27
BE - Belgio 26
LT - Lituania 24
UZ - Uzbekistan 24
IL - Israele 21
MA - Marocco 19
CL - Cile 15
KE - Kenya 15
CZ - Repubblica Ceca 14
TN - Tunisia 14
PY - Paraguay 13
BO - Bolivia 12
EG - Egitto 12
JM - Giamaica 12
JO - Giordania 12
AZ - Azerbaigian 11
ET - Etiopia 10
IR - Iran 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DZ - Algeria 9
SK - Slovacchia (Repubblica Slovacca) 9
UY - Uruguay 9
GR - Grecia 7
PE - Perù 7
PT - Portogallo 7
RS - Serbia 7
TW - Taiwan 7
AU - Australia 6
NP - Nepal 6
PA - Panama 6
HU - Ungheria 5
MM - Myanmar 5
RO - Romania 5
SY - Repubblica araba siriana 5
AO - Angola 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
PS - Palestinian Territory 4
QA - Qatar 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
CG - Congo 3
GE - Georgia 3
GY - Guiana 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
SC - Seychelles 3
BG - Bulgaria 2
GH - Ghana 2
HN - Honduras 2
KH - Cambogia 2
LU - Lussemburgo 2
LY - Libia 2
MR - Mauritania 2
NG - Nigeria 2
Totale 22.716
Salva come PNG Salva come JPEG
Città #
Stockholm 1.879
Singapore 1.292
Ann Arbor 1.272
Hong Kong 845
Ashburn 713
San Jose 681
Frankfurt am Main 521
Milan 436
Ho Chi Minh City 432
Fairfield 361
Hanoi 359
Dublin 328
Chandler 293
Dallas 284
Wilmington 270
Chicago 257
Toronto 255
Los Angeles 246
New York 241
Hefei 221
Santa Clara 219
Woodbridge 167
Boardman 164
The Dalles 153
Seattle 146
Houston 145
Beijing 130
Seoul 123
Cambridge 119
London 117
Lauterbourg 102
Princeton 98
Buffalo 78
Jakarta 78
Shanghai 75
Helsinki 74
Council Bluffs 72
Rome 72
São Paulo 72
Moscow 70
Dearborn 66
Munich 62
Orem 49
Zurich 48
Altamura 46
Lawrence 46
Haiphong 41
Warsaw 41
Da Nang 40
Monza 37
Biên Hòa 35
Johannesburg 33
Columbus 30
Florence 30
Ha Long 30
Turin 30
Nuremberg 29
Vienna 29
Rio de Janeiro 28
San Diego 28
Atlanta 26
Hải Dương 26
Montreal 26
Denver 25
Pune 25
Tokyo 24
Can Tho 23
Quận Bình Thạnh 23
Baghdad 22
New Delhi 22
Turku 22
Brussels 21
Jacksonville 21
Mumbai 21
Ninh Bình 21
Amsterdam 20
Guangzhou 20
Riyadh 20
Salt Lake City 20
Chennai 19
Tashkent 19
Belo Horizonte 18
Brooklyn 18
Naples 18
Boston 17
Lappeenranta 17
Bari 16
Bắc Ninh 16
Penang 16
Poplar 16
Dhaka 15
Phoenix 15
Vũng Tàu 15
Istanbul 14
Nanjing 14
Paris 14
Quận Một 14
Tampa 14
Bologna 13
Thái Nguyên 13
Totale 14.997
Salva come PNG Salva come JPEG
Nome #
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial 1.964
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 590
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 453
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 408
A second update on mapping the human genetic architecture of COVID-19 365
Mapping the human genetic architecture of COVID-19 347
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 342
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 340
Risk stratification in primary sclerosing cholangitis 334
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 334
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 331
Precision medicine in primary biliary cholangitis 328
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 319
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 318
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 316
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 294
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 293
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 292
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 288
New Therapeutic Targets in Autoimmune Cholangiopathies 284
Better end points needed in primary sclerosing cholangitis trials 282
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 279
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 273
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 267
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 262
Artificial Intelligence and liver: Opportunities and barriers 258
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 255
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 253
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 252
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 251
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 251
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 245
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 243
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 235
Artificial intelligence for precision medicine in autoimmune liver disease 234
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 233
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 233
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 229
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 229
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 228
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 227
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 226
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 226
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 226
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 225
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 224
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 216
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 216
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 215
X marks the spot in autoimmunity 208
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 205
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 201
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 200
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 200
The immunobiology of female predominance in primary biliary cholangitis 200
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 200
The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants 196
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 196
Cost of illness of Primary Biliary Cholangitis - a population-based study 185
Open challenges in the management of autoimmune hepatitis 179
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 177
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 177
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 174
The application of artificial intelligence in hepatology: A systematic review 169
The Role of Epigenetics in Primary Biliary Cholangitis 168
Gender differences in liver disease and the drug-dose gender gap 161
The role of ethnicity in autoimmune hepatitis 158
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 156
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 153
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 147
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 147
Bacterascites confers poor patient prognosis beyond MELD prediction 145
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 145
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 144
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model 142
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 142
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 134
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 131
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 130
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 129
GWAS and autoimmunity: What have we learned and what next 127
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 125
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 124
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 123
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 118
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 116
Genetics of Autoimmune Liver Diseases 112
Primary Sclerosing Cholangitis 112
Genetics of Primary Biliary Cholangitis 111
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 105
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 101
The genetic architecture of primary biliary cholangitis 101
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 98
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 97
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 91
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 87
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies 85
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 81
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 77
Primary Biliary Cholangitis 75
Totale 22.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/20221.051 107 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/20253.885 254 400 218 187 325 197 247 209 426 532 361 529
2025/202612.167 1.536 827 807 1.113 954 499 1.422 519 797 2.715 590 388
Totale 23.289